NORDITROPIN SIMPLEXX and NORDIFLEX
Reason for request
The absolute benefit of NORDITROPIN in adults with GH deficiency remains moderate.
The actual benefit of NORDITROPIN in children with GH deficiency remains substantial.
The actual benefit of NORDITROPIN in Turner syndrome remains substantial.
The actual benefit of NORDITROPIN in chronic renal impairment remains substantial.
The actual benefit of NORDITROPIN in children born small for gestational age with a birth weight and/or height < -2 SD, who have failed to show catch-up growth (growth velocity < 0 SD during the last year) by 4 years of age or later and whose growth retardation (current height) is below or equal to -3 SD and the adjusted parental height < -1 SD remains low.